Immune Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: New York NY United States (2010)
Status: Acquired by United General Ltd (2021)

Organization Overview

First Clinical Trial
2015
NCT01671956
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree